Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
31 participants
INTERVENTIONAL
2016-10-31
2020-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound Elastography
NCT00005770
The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients
NCT07259369
Efficacy of of Acupuncture Laser Therapy on Hemodialysis Patients
NCT07099352
Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis
NCT06098443
Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients
NCT00290238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study a mobile non-invasive NMR-MOUSE setup (a nuclear magnetic resonance spectroscopy measurement) is used to measure the hydration status of the skin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dialysis patients
In this group dialysis patients are measured by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) during their routine dialysis sessions. After a 5 min rest period the arm of the patients is placed onto the NMR-Mouse and measured before the beginning of dialysis. The arm examined is not the shunt arm. The area selected should not display any signs of skin disease or scars from previous surgeries. After the dialysis the same area is measured again in a second measurement. The measurement will be repeated on three different days with each patient.
Dermal nuclear magnetic resonance (NMR)-profile measurement
Nuclear magnetic resonance (NMR)-profile measurement of the dermis
Healthy volunteers
In this group "kidney-healthy" volunteers will be examined by NMR-Mobile Universal Surface Explorer® (NMR-Mouse) at three different days. The right/left arm or leg will be used for repeated measurement. Altogether 2 measurements per day are reformed in order to evaluate the reproducibility and variability.
Dermal nuclear magnetic resonance (NMR)-profile measurement
Nuclear magnetic resonance (NMR)-profile measurement of the dermis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dermal nuclear magnetic resonance (NMR)-profile measurement
Nuclear magnetic resonance (NMR)-profile measurement of the dermis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dialysis
* ability to perform NMR-measurement
* Eligibility to sign informed consent
* signed informed consent
Exclusion Criteria
* implanted cranial device
* implanted cochlea device
* intrauterine device
* other metallic implants
* tattoo, any skin disease or scars from surgery (in the area of measurement)
* previous skin treatment with cosmetics (of any kind) 24 hours prior to measurement
* wearing of earrings, piercings or hearings-aids during measurement
* participation in other clinical trials 30 days prior to participation in the SHN study
* no written informed consent
* any conditions, as determined by the examiner, that excludes the patient from participation in the study
* subjects with legal guardian
* pregnancy or lactation (a possible pregnancy of a participant before menopause will be excluded before inclusion in the study)
* subjects under employment or with any relation to the the sponsor or the investigator
* participation in any other study
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Technical and Macromolecular Chemistry, RWTH Aachen University
UNKNOWN
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jürgen Floege, M.D.
Role: PRINCIPAL_INVESTIGATOR
RWTH Aachen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of RWTH Aachen, Department of Medicine II
Aachen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Perlo J, Casanova F, Blumich B. Profiles with microscopic resolution by single-sided NMR. J Magn Reson. 2005 Sep;176(1):64-70. doi: 10.1016/j.jmr.2005.05.017.
Danieli E, Blumich B. Single-sided magnetic resonance profiling in biological and materials science. J Magn Reson. 2013 Apr;229:142-54. doi: 10.1016/j.jmr.2012.11.023. Epub 2012 Dec 8.
Perlo J, Casanova F, Blumich B. Single-sided sensor for high-resolution NMR spectroscopy. J Magn Reson. 2006 Jun;180(2):274-9. doi: 10.1016/j.jmr.2006.03.004. Epub 2006 Mar 31.
Medrano G, Eitner F, Floege J, Leonhardt S. A novel bioimpedance technique to monitor fluid volume state during hemodialysis treatment. ASAIO J. 2010 May-Jun;56(3):215-20. doi: 10.1097/MAT.0b013e3181d89160.
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005 Jan;45(1):142-61. doi: 10.1161/01.HYP.0000150859.47929.8e. Epub 2004 Dec 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.